What we do
Radiopharmacy sits at the most time‑sensitive point of the diagnostic pathway. Short half‑life products, strict regulation and fixed clinical schedules leave no margin for error. Alliance Medical Group operates radiopharmacy capability designed to perform reliably under these constraints, across regions and health systems.
Radiopharmacy is not simply about supply. It is about synchronising production, quality control and delivery within narrow clinical windows.
Alliance Medical Group’s radiopharmacy capability is designed around this reality. We operate licensed production and distribution infrastructure across the UK, Italy, Ireland, Iberia, Germany, Poland, Austria and the Netherlands, aligned closely with imaging delivery and clinical timetables.
This approach allows advanced diagnostics to function predictably, even in complex, multi‑site environments.
Keeping advanced diagnostics operational
Advanced imaging and nuclear medicine services depend on radiopharmaceuticals being available at the right place, at the right time, in the right condition.
Alliance Medical Group supports radiopharmacy services that align production and distribution with clinical demand, enabling PET-CT and nuclear medicine pathways to operate without disruption across regions. This keeps advanced diagnostics operational where timing is non‑negotiable.
Supporting regulated clinical use and research
Radiopharmacy operates within some of the most demanding regulatory frameworks in diagnostics.
Alliance Medical Group supplies registered radiopharmaceuticals for routine clinical use and holds the licences required to manufacture Investigational Medicinal Product Dociers (IMPDs) for clinical trials. This allows support for established diagnostic services and regulated research activity within the same controlled environment.
Health systems and providers
To maintain reliable PET-CT and nuclear medicine services through licensed, time‑critical radiopharmaceutical supply.
Clinicians and care teams
To deliver advanced diagnostic procedures with confidence in product quality, availability and regulatory compliance.
Cross-regional diagnostic networks
To support radiopharmaceutical supply across countries including Sweden, Finland, the Baltic states, Poland, Germany, Austria, the Netherlands and Serbia, with flexibility to extend supply across Europe where required.
Clinical trials and research programmes
To enable regulated access to registered and investigational radiopharmaceuticals for clinical research.
Find out how we work
Alliance Medical Group delivers radiopharmacy capability through specialist production and distribution services across the Group.
We continue to develop and grow our radiopharmacy network through investments in our existing, extensive radiopharmacy production facilities, and through acquisitions and key partnerships.
Delivering diagnostics
and insight at scale
